NCT02159482View on ClinicalTrials.gov

Pilot Study of Interferon Alfa for Patients Who Have Received Cancer Vaccines

PHASE2TerminatedINTERVENTIONAL

Enrollment

11

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions

Cancer

Interventions

DRUG

Interferon Alfa-2a

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER

NCT02159482 - Pilot Study of Interferon Alfa for Patients Who Have Received Cancer Vaccines | Biotech Hunter | Biotech Hunter